elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Temozolomide
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Temozolomide
RIS
0.002
(Research Intensity Score)
Papers
254
Top papers
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 · 1276 citations
Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy
2022 · 209 citations
Nanotherapy of Glioblastoma—Where Hope Grows
2025 · 41 citations
Unlocking glioblastoma: breakthroughs in molecular mechanisms and next-generation therapies
2025 · 29 citations
How did lomustine become standard of care in recurrent glioblastoma?
2020 · 237 citations
Newest papers
Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment
2026 · 2 citations
Nanotherapy of Glioblastoma—Where Hope Grows
2025 · 41 citations
Unlocking glioblastoma: breakthroughs in molecular mechanisms and next-generation therapies
2025 · 29 citations
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models
2025 · 19 citations
Glioblastoma metabolomics: uncovering biomarkers for diagnosis, prognosis and targeted therapy
2025 · 17 citations
A sample from the 100 top papers behind Temozolomide.
Create a free account to browse them all →
Temozolomide's history
Research intensity over time
Explore Temozolomide's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Temozolomide's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link